Chloroprocaine Hci Injection, Solution
Product Images NDC 51662-1401

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Chloroprocaine Hci (NDC 51662-1401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51662 1401 1 Vial Label

Label for Nesacaine (chloroprocaine HCl) Injection, USP 2% solution, containing 600 mg per 30 mL (20 mg per mL). Indicated for infiltration and nerve block only, not for caudal, epidural, or spinal anesthesia. The vial contains 30 mL multiple dose and includes methylparaben as a preservative.*

FDA Label Image

51662 1401 2 Pouch Labeling

Label for Nesacaine (Chloroprocaine HCl Injection, USP) 2% (20 mg/mL) in a 30 mL vial. The label displays the NDC 51662-1401-2, lot number, expiration date, and indicates use for infiltration and nerve block only. Manufactured by HF Acquisition Co LLC, Mukilteo, WA.*

FDA Label Image

51662 1401 3 Case Labeling

Label for NESAcaine (Chloroprocaine HCl) Injection USP 2% (20 mg/mL) in a 30 mL vial, box of 25. The label includes NDC 51662-1401-3, lot number 123456, and expiration date 2030-01-01. Manufactured by HF Acquisition Co LLC in Mukilteo, WA.*

FDA Label Image

51662 1401 3 Rfid Labeling

A close-up image of a label on a package for CHLOROPROCAINE HCI injection, solution. The label includes barcode symbols, numeric codes such as (01) 00351662140130, (17) 300101, and (21) 139004034245. It indicates distribution by HF Acquisition Co., LLC, Mukilteo, WA 98275, and states RX ONLY with instructions to see the manufacturer’s package insert.*

FDA Label Image

Description (Description 1)

A data table listing formulations of products under the Nesacaine brand, showing concentrations of Chloroprocaine HCl, Sodium Chloride, Disodium EDTA dihydrate, and Methylparaben in milligrams per milliliter for Nesacaine 1%, Nesacaine 2%, Nesacaine-MPF 2%, and Nesacaine-MPF 3%. The table differentiates the presence and amounts of excipients across these four product variants.*

FDA Label Image

Dosage (Dosage)

A table presenting anesthetic procedures with Chloroprocaine HCl injection solution, detailing solution concentration percentage, volume in milliliters, and total dose in milligrams for each procedure. Procedures include Mandibular, Infraorbital, Brachial plexus, Digital (without epinephrine), Pudendal, and Paracervical, with respective concentration percentages ranging from 1 to 2% and variable volume and dose amounts.*

FDA Label Image

How Supplied 1 (How Supplied 1)

A data table presenting product codes, units of sale, strengths, and packaging details for two related drug products. The table lists concentrations of 1% (10 mg/mL) and 2% (20 mg/mL) solutions, each in 30 mL multiple dose vials, with corresponding NDC numbers and a unit pack size of 25 vials.*

FDA Label Image

How Supplied 2 (How Supplied 2)

A data table listing product codes, units of sale, strength, and packaging details for chloroprocaine hydrochloride injection. It shows two strengths: 2% (20 mg/mL) and 3% (30 mg/mL). Units of sale are NDC packages of 25 vials, each vial being a 20 mL single-dose vial with corresponding NDCs.*

FDA Label Image

Logo (Logo)

FDA Label Image

Precautions (Precautions)

A table categorizing various drug classes alongside examples of drugs in each category. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with examples listed for each grouping.*

FDA Label Image

Serialized Labeling (Serialized Labeling)

Prescription drug vial labeled Nesacaine (chloroprocaine HCl Injection, USP) 2% (600 mg/30 mL, 20 mg/mL) injection solution. The 30 mL multiple dose vial is distributed by HF Acquisition Co LLC, DBA HealthFirst. The label indicates use for infiltration and nerve block only, with additional instructions and safety information.*

FDA Label Image

Structure (Structure)

Chemical structure of Chloroprocaine HCl, depicting a substituted aromatic ring with amino and chloro groups, ester and amine side chains, and associated hydrochloride salt.*

FDA Label Image

Vial 1 (Vial 1)

The image shows a clear glass vial with a purple cap containing Nesacaine (chloroprocaine HCl) Injection, USP. The vial label indicates the concentration is 2% (20 mg/mL) in a 30 mL multiple-dose vial. The label includes usage information for infiltration and nerve block only and specifies the inclusion of methylparaben.*

FDA Label Image

Vial 2 (Vial 2)

A close-up image of a clear glass vial with a purple flip-off cap, containing a sterile injection solution. The visible label includes storage instructions and handling precautions, mentioning 'Sterile, nonpyrogenic,' temperature storage range (20° to 25°C), and warnings to protect from light and discard if discolored. The label also shows 'Fresenius Kabi USA, LLC' as the manufacturer.*

FDA Label Image

Vial 3 (Vial 3)

A clear glass vial with a purple cap containing a colorless liquid. The visible label includes a barcode, lot number, and expiration date, but the proprietary name and other details are not fully visible. The vial is consistent with a pharmaceutical injection solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.